Verana Health Secures $150m Funding From J&J And Novo To Support Development Of A Real-World Database For Drug And Device Development
Verana Health, a healthcare technology company, has recently launched an AI-powered data analytics engine and has a new CEO, which has garnered attention from investors, including Johnson & Johnson Innovation and Novo Nordisk’s Novo Growth investment arm. The company has closed its largest funding round to date, raising $150 million, which it plans to use to expand its technology and physician-focused features and to build out its data network through new partnerships with medical societies and healthcare data collectors.
What is verana health aipowered innovation novo growthparkfiercebiotech ?
Verana Health is working to create a big collection of real-life medical data by gathering information from over 20,000 healthcare providers and medical organizations. The company’s population health analytics tool, VeraQ, uses AI to analyze and organize this data, accelerating clinical trial recruitment and providing insights for drug and device developers.
In short, Verana Health is doing something pretty cool. They’re gathering up all the scattered bits of health info out there and making sense of it. You know how your doctor’s notes are often hard to read and don’t always match up with what other docs are saying? Verana Health is fixing that. They’re making it easier for all healthcare pros to get on the same page and make the best choices for you. Dr. Parke, who’s a really smart guy and the big boss of eye docs in America, as well as the executive chairman of Verna Health, thinks this is a big deal. It means doctors can make decisions that can make your life better. And that’s what healthcare is all about – making things better for patients to make their lives whole again!
Also Check Hawthorne Effect 20m Series 24madamsfiercebiotech
The new funding round will help Verana Health to expand its reach and to build out its data network by partnering with medical societies and other healthcare data collectors. Johnson & Johnson Innovation and Novo Nordisk’s Novo Growth investment arm will also send representatives to join Verana’s board of directors, bringing their expertise to the company’s future growth and development.
All in all, with the support of investors and medical societies, Verana Health is poised to continue expanding its real-world evidence network and driving innovation in the healthcare technology industry. So verana health aipowered innovation novo growthparkfiercebiotech means Verana Health lands J&J, Novo backing in $150M round to fund real world database for device development and drug.
